An Integrative Harm Reduction Approach to Treating Substance Misuse with Special Attention to Cannabis (6 hours)

This course is approved for 6 hours of continuing education by the Order of Psychologists of Quebec (OPQ) and the Canadian Counselling and Psychotherapy Association (CCPA).

Accumulating evidence is moving us away from moral, criminal and reductive disease models toward understanding substance use as a psychobiosocial process with multiple dimensions and individual variations. This shift calls for a personalized, integrative harm reduction psychotherapy for problematic substance users. Dr. Tatarsky will discuss the limitations of the dominant disease model and abstinence-only recovery narrative and introduce the psychobiosocial model of addiction and IHRP based on it. IHRP integrates harm reduction principles into psychotherapy and substance use treatment. It combines relational psychoanalytic, cognitive behavioral and mindfulness techniques in a harm reduction frame to support positive change in substance use and related issues. IHRP’s seven therapeutic tasks will be described: managing the therapeutic alliance with harm reduction listening, the relationship as agent of healing, enhancing self-regulation and self-management skills, assessment as treatment, embracing ambivalence, harm reduction goal setting and personalized planning for positive change. Specific skills and strategies that participants can begin using immediately will be demonstrated. Given that Canada is moving toward legalizing marijuana (MJ), the workshop will give special attention to understanding the potential benefits and risks associated with MJ and the application of IHRP to develop ideal relationships with MJ.

Objectives

About the speaker - Dr. Andrew Tatarsky

Dr. Andrew Tatarsky has developed Integrative Harm Reduction Psychotherapy (IHRP) for treating the spectrum of risky and addictive behavior. IHRP brings psychoanalysis, CBT and mindfulness together in a harm reduction frame. The therapy has been described in his book, Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems, and a series of papers. Dr. Tatarsky holds a PhD in clinical psychology from the City University of New York and is a graduate of New York University’s Postdoctoral Program in Psychoanalysis and Psychotherapy. He is Founder and Director of the Center for Optimal Living in NYC, a treatment and training center; founding member and Past-President, Division on Addiction of New York State Psychological Association, and Member of the Medical and Clinical Advisory Boards of the New York State Office of Alcoholism and Substance Abuse Services. Dr. Tatarsky has trained professionals in harm reduction, nationally and internationally.

Tax information

Medipsy is recognized by Revenu Quebec as an educational institution making our courses tax-deductible. Our accreditation number is 16-07-3871

The registration fee includes all applicable taxes.
Our GST number is 82873 880 RT0001
Our PST number is 1218616310